Inhibikase Therapeutics Ratios (2020-2025) | IKT

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -202.17%-192.12%-1,779.72%-708.85%-187.40%-193.40%-1,361.26%-259,342.54%-10,081.47%-70,817.14%-61,645.36%-6,819.64%-7,307.62%-5,328.07%-5,993.38%-440,356,600.00%
EBIT Margin -199.42%-188.50%-1,761.44%-704.66%-186.56%-192.83%-1,361.22%-259,334.41%-10,081.46%-70,817.14%-61,899.59%-6,819.64%-7,307.62%-5,328.07%-5,993.38%-440,356,600.00%
EBITDA Margin -199.42%-188.50%-1,761.44%-704.66%-186.56%-192.83%-1,361.22%-259,334.41%-10,081.46%-70,827.24%-61,277.40%-6,819.64%-7,307.62%-3,794.07%-5,773.14%-440,356,600.00%
Operating Margin -199.42%-188.50%-1,761.44%-704.66%-186.56%-192.83%-1,361.22%-259,334.41%-10,081.46%-70,817.14%-61,899.59%-6,819.64%-7,307.62%-5,328.07%-5,993.38%-440,356,600.00%
Net Margin -202.17%-192.12%-1,779.72%-708.85%-187.40%-193.40%-1,361.26%-259,342.54%-10,081.47%-70,817.14%-61,645.36%-6,819.64%-7,307.62%-5,328.07%-5,993.38%-440,356,600.00%
FCF Margin -94.33%-1.33%200.41%-555.42%-279.58%-311.55%-615.14%-210,690.17%-8,546.84%-66,480.49%-78,245.73%-5,594.77%-9,256.10%-3,921.82%-5,159.16%-344,243,100.00%
Efficiency
Assets Average 13.33M30.54M47.54M44.17M40.43M36.19M31.29M26.76M26.55M25.26M20.11M16.19M12.79M9.95M6.60M51.49M96.44M91.57M84.22M
Equity Average -4.77M-4.98M2.33M8.91M27.55M45.11M40.79M36.21M31.76M27.32M23.09M23.16M22.37M17.24M13.00M8.88M5.94M2.28M47.17M90.30M82.89M76.48M
Invested Capital -4.70M-4.83M-5.13M9.78M8.04M47.05M43.16M38.42M34.01M29.50M25.28M21.18M25.43M19.61M15.17M11.36M6.93M5.25M-0.39M94.98M85.81M80.09M72.90M
Asset Utilization Ratio 0.140.100.070.070.040.010.000.000.010.010.020.02
Leverage & Solvency
Interest Coverage Ratio -72.73-52.08-96.33-168.21-222.54-336.50-0.03M-0.03M-0.93M
Debt to Equity 0.030.030.010.010.010.010.010.010.010.020.03-0.270.000.000.00
Debt Ratio 0.020.020.010.000.010.010.010.010.010.010.020.030.000.000.00
Equity Ratio 0.660.680.960.940.900.890.870.880.840.900.870.840.760.610.58-0.120.960.910.900.92
Times Interest Earned -72.73-52.08-96.33-168.21-222.54-336.50-0.03M-0.03M-0.93M
Valuation
Enterprise Value -0.01M-0.01M-0.02M52.32M50.80M3.94M2.91M-3.77M0.72M-13.48M-3.58M-10.44M-6.66M-2.25M-9.40M-5.41M4.24M-0.10M6.46M120.83M69.63M57.30M43.39M
Market Capitalization 66.28M60.41M50.77M47.75M36.98M37.34M18.73M22.96M12.61M19.06M18.69M7.43M7.84M13.99M7.84M9.70M218.38M162.81M144.97M120.72M
Return Ratios
Return on Sales -4.08%-2.69%-2.40%-3.35%-4.77%-9.65%-49.07%-304.39%-146.71%-128.12%-78.43%-61.78%-77.12%
Return on Capital Employed -0.50%-0.25%-0.24%-0.37%-0.67%-0.79%-0.76%-0.88%-1.15%-1.58%-2.36%-3.04%-11.84%-0.60%
Return on Assets -0.37%-0.23%-0.23%-0.33%-0.42%-0.52%-0.60%-0.68%-0.68%-0.78%-1.00%-1.24%-1.58%-1.91%-3.04%-0.56%
Return on Equity -1.22%-0.55%-0.26%-0.24%-0.36%-0.46%-0.59%-0.69%-0.78%-0.79%-0.88%-1.16%-1.55%-2.27%-3.20%-8.79%-0.61%